Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
David L. Kendler
Sign up to set email alerts
276
Publications
13,461
Citation Statements Received
5,584
Citation Statements Given
How they've been cited
21,071
523
12,871
67
How they cite others
9,628
366
5,181
37
Affiliations
University of British Columbia
,
Osteoporosis Canada
Publications
Order By: Most citations
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Khan
1
,
Morrison
2
,
Hanley
3
et al.
2014
Abstract
Show
1,401
22
1,269
9
Get access via publisher
Add to collection
Cite
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Bone
1
,
Wagman
2
,
Brandi
3
et al.
2017
The Lancet Diabetes & Endocrinology
1,020
26
698
2
Get access via publisher
Add to collection
Cite
Alendronate for the Treatment of Osteoporosis in Men
ORWOLL
1
,
Ettinger
2
,
Weiss
3
et al.
2000
N Engl J Med
Abstract
Show
944
24
496
4
Get access via publisher
Add to collection
Cite
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
Bone
1
,
Bolognese
2
,
Yuen
3
et al.
2011
The Journal of Clinical Endocrinology & Metabolism
Abstract
Show
640
29
433
1
Get access via publisher
Add to collection
Cite
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
Hodsman
1
,
Bauer
2
,
Dempster
3
et al.
2005
Abstract
Show
708
6
435
1
Get access via publisher
Add to collection
Cite
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Langdahl
1
,
Libanati
2
,
Crittenden
3
et al.
2017
The Lancet
512
24
403
3
Get access via publisher
Add to collection
Cite
Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Position Development Conference
Baim
1
,
Binkley
2
,
Bilezikian
3
et al.
2008
Journal of Clinical Densitometry
Abstract
Show
455
2
378
0
Get access via publisher
Add to collection
Cite
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
Kendler
1
,
Marín
2
,
Zerbini
3
et al.
2018
The Lancet
617
11
362
2
5
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6